Defining thyroid cancer

 

 

 

 

 

 

 

 

 

 

 

Terms of Use 

What is cancer of the thyroid?

Cancer of the thyroid is a disease in which cancer (malignant) cells are found in the tissues of the thyroid gland. The thyroid gland is at the base of the throat. It has two lobes, one on the right side and one on the left. The thyroid gland makes important hormones that help the body function normally.

Cancer of the thyroid is more common in women than in men. Most patients are between 25 and 65 years old. People who have been exposed to large amounts of radiation, or who have had radiation treatment for medical problems in the head and neck have a higher chance of getting thyroid cancer. The cancer may not occur until 20 years or longer after the initial radiation treatment.

A doctor should be seen if there is a lump or swelling in the front of the neck or in other parts of the neck. If there are symptoms, a doctor will feel the patient's thyroid and check for lumps in the neck. The doctor may order blood tests and special scans to see whether a lump in the thyroid is making too many hormones.
 
Depending on test results and individual risk factors. The doctor may want to take a small amount of tissue from the thyroid. This is called a biopsy. To do this, a small needle is inserted into the thyroid at the base of the throat and some tissue is drawn out. The tissue is then looked at under a microscope to see whether it contains cancer.

There are four main types of cancer of the thyroid (based on how the cancer cells look under a microscope): papillary, follicular, medullary, and anaplastic. The chance of recovery (prognosis) depends on the type of thyroid cancer, whether it is just in the thyroid or has spread to other parts of the body (stage), and the patient's age and overall health. Some types of thyroid cancer grow much faster than others.

The genes in our cells carry the hereditary information from our parents. An abnormal gene has been found in patients with some forms of thyroid cancer. If medullary thyroid cancer is found, the patient may have been born with a certain abnormal gene which may have led to the cancer. Family members may have also inherited this abnormal gene. Tests have been developed to determine who has the genetic defect long before any cancer appears.
It is important that the patient and his or her family members (children, grandchildren, parents, brothers, sisters, nieces and nephews) see a doctor about tests that will show if the abnormal gene is present. These tests are confidential and can help the doctor help patients. Family members, including young children, who don't have cancer, but do have this abnormal gene, may reduce the chance of developing medullary thyroid cancer by having surgery to safely remove the thyroid gland (thyroidectomy).
 
 

 Key Points Summary

 
  • Thyroid cancer is the most common endocrine cancer.
  • Thyroid cancer is a cancerous tumor or growth located within the thyroid gland
  • Thyroid cancer is one of the few cancers that has increased in incidence rates over the past several years. There are expected to be 11% more new cases in 2008 than in 2007 in the United States
  • The American Cancer Society estimates that there will be about 37,340 new cases of thyroid cancer in the U.S. in 2008. Of these new cases, about 28,410 will occur in women and about 8,930 will occur in men. About 1,590 people (910 women and 680 men) will die of thyroid cancer in 2008.
  • Many patients, especially in the early stages of thyroid cancer, do not experience symptoms. However, as the cancer develops, symptoms can include a lump or nodule in the front of the neck, hoarseness or difficulty peaking, swollen lymph nodes, difficulty swallowing or breathing, and pain in the throat or neck
    There are several types of thyroid cancer:  papillary, follicular, medullary, anaplastic, and variants.

Papillary and follicular thyroid carcinomas

 
Referred to as well-differentiated thyroid cancer and account for 80–90% of all thyroid cancers. Variants include tall cell, insular, columnar, and Hurthle cell. Their treatment and management are similar. If detected early, most papillary and follicularthyroid cancer can be treated successfully.
 

Medullary thyroid carcinoma (MTC)

 
Accounts for 5-10% of all thyroid cancers. Medullary cancer is easier to treat and control if found before it spreads to other parts of the body. There are two types of medullary thyroid cancer: sporadic and familial.
 
Genetic testing (of the RET protooncogene should be performed in all patients with MTC to determine whether there are genetic changes that predict the development of MTC. In individuals with these genetic changes, removal of the thyroid during childhood has a high probability of being curative.

 

Anaplastic thyroid carcinoma

 
The least common and accounts for only 1–2% of all thyroid cancer. This type is difficult to control and treat because it is a very aggressive type of thyroid cancer.

  • Treatments for thyroid cancer include surgery, radioactive iodine treatment, external beam radiation therapy, and chemotherapy. In most cases, patients undergo surgery to remove most of the thyroid gland, and are treated with thyroid hormone replacement therapy.

 

  • For those with papillary and follicular thyroid cancer, the dose of thyroid hormone replacement is usually high enough to suppress thyroid stimulating hormone (TSH) well below the range that is normal for someone not diagnosed with thyroid cancer, to help prevent the growth of cancer cells while providing essential thyroid hormone to the body.

 

  • Factors associated with thyroid cancer include a family history of thyroid cancer, gender (women  have a higher incidence of thyroid cancer), age (the majority of cases occur in people over 40, although thyroid cancer affects all age groups from children through seniors), and prior exposure of the thyroid gland to radiation.

 

  • While the prognosis for most thyroid cancer patients is very good, the rate of recurrence can be up to 30%, and recurrences can occur even decades after the initial diagnosis. Therefore, it is important  that patients get regular follow-up examinations to detect whether the cancer has re-emerged. Monitoring should continue throughout the patient’s lifetime.

 

  • Periodic follow-up examinations can include a review of the medical history together with selected blood tests appropriate for the type of cancer and stage of treatment (TSH, thyroglobulin, CEA, and  calcitonin levels), physical examination, and imaging techniques (ultrasound, radioiodine whole body scan, chest X-ray, CT, MRI, PET, and other tests).

 


Metatastic Thyroid Cancer

(spread to distant locations) 

 
The guidelines cover diagnosis, surgery, staging, radioiodine ablation, post-therapy scans, TSH suppression, thyroglobulin testing, ultrasound, RAI scans, other imaging techniques, metastatic disease, and many other topics. The thyroid cancer specialist physicians who developed the guidelines included many ThyCa medical advisors and conference and workshop speakers.

 


   

Attachments (12)

  • Cutaneous Manifestation of Thyroid Cancers.pdf - on Jun 21, 2008 6:32 PM by Hope Angel Rivera (version 1)
    786k View Download
  • Familial Occurrence of NonMedullary Thyroid Cancer Study.pdf - on Jun 21, 2008 6:32 PM by Hope Angel Rivera (version 1)
    32k View Download
  • Local Recurrence in Head and Neck Cancer Study.pdf - on Jun 21, 2008 6:30 PM by Hope Angel Rivera (version 1)
    416k View Download
  • Lymph Node Metastasis in Head and Neck Cancer.pdf - on Jun 21, 2008 6:30 PM by Hope Angel Rivera (version 1)
    802k View Download
  • New Malignancies Among Cancer Survivors.pdf - on Jun 21, 2008 6:31 PM by Hope Angel Rivera (version 1)
    3218k View Download
  • New Malignancies Following Thyroid Cancer.pdf - on Jun 21, 2008 6:31 PM by Hope Angel Rivera (version 1)
    632k View Download
  • Persistence of Genetically Altered fields in Head and Neck Cancer.pdf - on Jun 21, 2008 6:31 PM by Hope Angel Rivera (version 1)
    200k View Download
  • SJCCFCancerSuicidesStudies.pdf - on Nov 23, 2008 7:44 AM by Wilma Colon-Ariza (version 1)
    259k View Download
  • SJCCF_AES-on-the-rise-analysis.pdf - on Nov 23, 2008 7:44 AM by Wilma Colon-Ariza (version 1)
    576k View Download
  • SJCCF_AES_ThyCa_Q%26A.pdf - on Nov 23, 2008 7:43 AM by Wilma Colon-Ariza (version 1)
    327k View Download
  • SJCCF_AES_ThyroidCancerRiskFactors.pdf - on Nov 23, 2008 7:43 AM by Wilma Colon-Ariza (version 1)
    290k View Download
  • Understanding_Thyroid_Cancer[1].pdf - on Jul 12, 2008 5:13 PM by Hope Angel Rivera (version 1)
    5415k View Download

EMERGENCY HEALTH ID

Medic Alert Foundation
 

Medical Identification Emblems and Emergency Electronic Medical Records DatabasePlease enter promotional code 750 and Ambassador Number 10456 where indicated during enrollment. If you or someone you know cannot afford this life saving tool please ask us about the hardship sponsorship program.

 

VISIT OUR A-STORE

  Holiday Shopping & More !

WELLNESS POSSIBILITIES

- $25 or more Good for their choice of
services -- featuring 150+ ways to relax,
relieve pain, reduce stress, and live
healthier, happier & easier.
 Enter Promo Code Stevie
 

PREPAID LEGAL SERVICES

Life Events Legal Plans
HealthCare Proxy
Bankruptcy & Collections
Wills & Trusts
 

SUBSCRIBTION CORNER